Nexalin Technology, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Nexalin Technology, Inc. (NXL) had Deferred Tax Assets, Operating Loss Carryforwards of $6.59 million as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-25
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.59M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $5.00M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $3.50M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $3.26M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $6.59M 10-K · filed 2026-03-25 |
| 2024-12-31 | $5.00M 10-K · filed 2026-03-25 |
| 2023-12-31 | $3.50M 10-K/A · filed 2025-09-23 |
| 2022-12-31 | $3.26M 10-K · filed 2024-03-27 |
| 2021-12-31 | $2.96M 10-K · filed 2023-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |